Division of Cardiology

Robert McKelvie

BSc (University of Western Ontario), MSc (University of Western Ontario), MD (University of Western Ontario), PhD (McMaster University), FRCPC

Professor Emeritus, Division of Cardiology, Department of Medicine

Associate Member, Graduate Studies in Human Biodynamics, McMaster University
Member, Graduate Faculty, Graduate Program in Medical Sciences 
Member, Faculty of Health Sciences Graduate Program in Clinical Health Sciences - Health Research Methodology
Chair, Canadian Cardiovascular Society Heart Failure Consensus Conference Program
Member, Operations Committee, Cardiac Ambulatory Clinic, Hamilton Health Sciences
Medical Director, Exercise Laboratory - Hamilton Health Sciences, General Site
Medical Director, Cardiac Health and Rehabilitation Centre - Hamilton Health Sciences
Medical Director, Heart Function Clinic, Hamilton Health Sciences

Selected Publications

  1. Keteyian SJ, Issac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE, on behalf of HF-ACTION Investigators. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J, 2009;158:S72-S77.
  2. Howlett JG, McKelvie RS, Arnold JMO, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, Heckman GA, Herd AM, Isaac D, Jong P, Kouz S, Liu P, Mann E, Moe GW, Tsuyuki RT, Ross HJ, White M. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol, 2009;25(2):85-105.
  3. Heckman G, McKelvie RS. Diagnosis and management of heart failure with preserved ejection fraction in older adults. Geriatrics & Aging, 2009;12(2):93-96.
  4. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston Miller, N, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL, for the HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION Randomized Controlled Trial. JAMA, 2009;301(14):1439-1450.
  5. McKelvie RS. The CHARM program: the effects of candesartan for the management of patients with chronic heart failure. Expert Rev. Cardiovasc. Ther. 2009;7(1):9-16.
  6. White M, Rouleau J-L, Afzal R, Floras J, Yusuf S, McKelvie RS. Effects of enalapril, candesartan or both on neurohumoral activation and left ventricular volumes and function in patients with heart failure not treated with a beta-blocker. Ther Adv Cardiovasc Dis 2009;3:113-121.
  7. Felker GM, Whellan D, Kraus Wm E, Clare R, Zannad F, Donahue M, Adams K, McKelvie R, Pina HL, O’Connor CM, for the HF-ACTION Investigators. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the heart failure HF-ACTION study. Am Heart J 2009:158(4):S37-S44.
  8. McKelvie RS, Komajda M, McMurray J, Zile M, Ptaszynska A, Donovan M, Carson P, Massie BM, for the I-PRESERVE Investigators. Baseline plasma NT-proBNP and clinical characteristics: Results from the irbesartan in heart failure with preserved ejection fraction trial. J Cardiac Fail 2010;16:128-134.
  9. Volpe M, McKelvie R, Drexler H. Hypertension as an underlying factor in heart failure with preserved ejection fraction. J Clin Hypertens (Greenwich) 2010;12(4):277-283.
  10. Zile MR, Gaasch Wm H, Anand IS, Haass M, Little Wm C, Miller AB, Lopez-Sendon J, Teerlink RJ, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE, for the I-Preserve Investigators. Mode of death in patients with heart failure and a preserved ejection fraction: results from irbesartan in heart failure with preserved ejection fraction study (I-PRESERVE) Trial. Circulation 2010;121:1393-1405.
  11. Kuenzli A, Bucher HC, Anand I, Arutiunov G, Kum LC, McKelvie R, Afzal R, White M, Nordmann AJ. Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure. PLoS ONE 2010;5(4):e9946.
  12. Howlett JG, McKelvie RS, Arnold JMO, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, Heckman GA, Herd AM, Isaac D, Jong P, Kouz S, Liu P, Mann E, Moe GW, Tsuyuki RT, Ross HJ White M. The 2010 Canadian Cardiovascular Society Guidelines for the diagnosis and management of Heart failure Update: Heart Failure in Ethnic Minority Populations, Heart Failure and Pregnancy, Disease Management, and Quality Improvement/Assurance Programs. Can J Cardiol 2010;25(2):85-105.
  13. McMurren C, Montour A, Heckman G, Kaasalainen S, Stolee P, Strachan P, McAiney C, Demers C, McKelvie R, Kelly M, van der Horst ML, Habjan S, Tjam E, D’Elia T. Health care provider perceptions of heart failure management in the LTC context. Can Geriatric J, 2010;13:49-50.
  14. Montour A, McMurren C, Heckman G, Kaasalainen S, Stolee P, Strachan P, McAiney C, Demers C, McKelvie R, Kelly M, van der Horst ML, Habjan S, Tjam E, D’Elia T. Adapting the Canadian Cardiovascular Society recommendations on heart failure for long-term care homes: Methodology for a consensus-based approach. Can Geriatric J 2010;13:50-51.